This week’s UK tech funding deals include newly minted unicorn Verdiva Bio, smartphone maker Nothing and AI CCTV startup RoboK.
UKTN tracked £381.3m worth of UK tech investment this week (06 January to 10 January), in our first funding roundup of 2025.
Here’s your weekly roundup of UK tech startup funding deals.
Verdiva Bio – £333.5m
Sector: Biotech
HQ: London
Round: Series A
Investors: Forbion and General Atlantic
Founded in 2024, Verdiva Bio is developing a weight loss medication to rival the success of Ozempic.
Nothing – £30m
Sector: Smart phones
HQ: London
Round: Debt financing
Investors: Santander
Founded in 2020, Nothing develops consumer hardware such as bluetooth headphones and more recently a challenger smart phone.
Nsave – £14.8m
Sector: Fintech
HQ: London
Round: Series A
Investors: TQ Ventures, Sequoia Capital, Y Combinator, ACE Ventures, and Proton Foundation
Founded in 2021, Nsave provides financial accounts to people living in high-inflation countries.
VitVio – £1.5m
Sector: Health tech/AI
HQ: London
Round: Pre-seed
Investors: LDV Capital, Bek Ventures, Tiny Supercomputer Investment Company, and angels
Founded in 2023, VitVio develops computer vision technology to track the performance of medical procedures.
RoboK – £1m
Sector: AI
HQ: Cambridge
Round: Grant
Investors: UKRI
Founded in 2017, RoboK is developing technology to incorporate AI into CCTV systems.
Mulder – £500,000
Sector: Health tech/Blockchain
HQ: London
Round: Pre-seed
Investors: SFC Capital and Innovate UK
Founded in 2023, Mulder is developing a blockchain to increase the transparency in the medical supply chain.